The use of TES-therapy in complex the treatment of stable angina II-III functional class

Abstract

The article is devoted to the application of TES-therapy in the complex treatment of angina pectoris II-III functional class. To assess the efficacy of treatment was assessed cytokine status (IL-1β, IL-4, IL-6, IL-10) and hormonal profile (cortisol, ACTH, β-endorphin) in patients with stable angina II-III functional class. All patients were divided into 2 groups: 1st (n=30) therapy of angina and for protocol 2 (n=30) therapy angina protocol and TES-therapy. It is shown that patients of the 1st group is not marked to normalize the level of the studied cytokines. In the 2nd group of patients the level of the studied cytokines was significantly decreased (p<0.01), and levels of ACTH, cortisol and β-endorphin significantly (p<0.01) increased. Thus, TES-therapy conducted during the 2nd group of patients, contributes to the correction of cytokine imbalance and the hormonal profile that suggests its inclusion in the standard therapy of angina.